cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA337521 | endometrium | .a | 143 to 353 | 1 to 212 | 212/212 (100 %) | 1 diff (99.6 %id) | |||
AA382601 | testis | .a | 761 to 955 | 1 to 195 | 195/195 (100 %) | 1 diff (99.5 %id) | |||
BP381502 | adipose tissue | .a | 115 to 726 | 1 to 612 | 612/612 (100 %) | 2 diff (99.7 %id) | |||
AF049611 | brain frontal cortex | .a | 1056 to 1739 | 1 to 684 | 684/684 (100 %) | 0 diff (100 %id) | |||
AK000014 | adipose tissue | .a | 115 to 1651 | 1 to 1537 | exact | available from FLJ, AAA | Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) | 1537/1537 (100 %) | 0 diff (100 %id) |
AK026074 | .a | 89 to 1651 | 1 to 1563 | F129S | available from FLJ, AAA | Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) | 1563/1563 (100 %) | 1 diff (100.0 %id) | |
AY358992 | .a | 120 to 1654 | 1 to 1535 | exact | tiling clone, | 1535/1535 (100 %) | 0 diff (100 %id) | ||
BC001342 | Cervix, carcinoma | .a | 131 to 1651 | 1 to 1521 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) | 1521/1521 (100 %) | 0 diff (100 %id) |
BF171130 | blood | .d-u | 965 to 1372 | 1 to 414 | 414/414 (100 %) | 16 diff (96.2 %id) | |||
BF845190 | head_neck | .f-u | 357 to 952 | 4 to 600 | tiling clone, | 597/603 (99 %) | 8 diff (98.7 %id) | ||
BI021762 | marrow | .f-u | 1 to 421 | 11 to 428 | tiling clone, | 418/428 (97 %) | 7 diff (98.4 %id) | ||
BI023084 | marrow | .g-u | 394 to 766 | 17 to 390 | tiling clone, | 374/390 (95 %) | 6 diff (98.5 %id) | ||
DA305368 | hippocampus | .a | 791 to 1351 | 2 to 562 | capped | 561/561 (100 %) | 1 diff (99.9 %id) | ||
BF725081 | eye, Iris | .d-u | 1137 to 1577 | 452 to 12 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 441/452 (97 %) | 0 diff (100 %id) | |
BF725082 | eye, Iris | .d-u | 1 to 531 | 1 to 531 | tiling clone, | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 531/531 (100 %) | 0 diff (100 %id) | |
BX096768 | .j | 1 to 458 | 1 to 458 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) | 458/458 (100 %) | 0 diff (100 %id) | |
BX115479 | pooled | .l-u | 1 to 415 | 1 to 415 | M18I | tiling clone, AAA | Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) | 415/415 (100 %) | 1 diff (99.8 %id) |
BX117362 | .i | 1 to 545 | 1 to 545 | exact | tiling clone, | 545/545 (100 %) | 0 diff (100 %id) | ||
BX280687 | adrenal cortex carcinoma, cell line, adrenal gland | .a | 561 to 1043 | 1 to 483 | 483/483 (100 %) | 0 diff (100 %id) | |||
CN311011 | embryonic stem cells, DMSO-treated H9 cellline | .a | 443 to 817 | 1 to 375 | 375/375 (100 %) | 1 diff (99.8 %id) | |||
CR747569 | adrenal cortex carcinoma, cell line, adrenal gland | .a | 561 to 1044 | 12 to 495 | 484/495 (97 %) | 6 diff (98.8 %id) | |||
BX409859 | T cells (Jurkat cell line) | .a | 758 to 1657 | 1 to 899 | 899/899 (100 %) | 9 diff (99.0 %id) | |||
BX421974 | T cells (Jurkat cell line) | .a | 98 to 855 | 1 to 757 | 757/757 (100 %) | 4 diff (99.5 %id) | |||
BX436104 | T cells (Jurkat cell line) | .d-u | 905 to 1565 | 659 to 1 | 659/892 (73 %) | 23 diff (97.5 %id) | |||
CV025162 | mixed | .a | 262 to 866 | 1 to 600 | 600/633 (94 %) | 6 diff (99.1 %id) | |||
BX486617 | .a | 87 to 839 | 1 to 751 | 751/751 (100 %) | 3 diff (99.7 %id) | ||||
AL710740 | human skeletal muscle | .a | 94 to 540 | 1 to 447 | 447/447 (100 %) | 1 diff (99.8 %id) | |||
BX486274 | .a | 87 to 517 | 1 to 431 | 431/431 (100 %) | 1 diff (99.8 %id) | ||||
CD674712 | eye, lens | .d-u | 801 to 1494 | 1 to 694 | 694/694 (100 %) | 2 diff (99.8 %id) | |||
DB523357 | testis | .d-u | 1098 to 1572 | 1 to 475 | Submitted on the opposite strand | 475/475 (100 %) | 0 diff (100 %id) | ||
DB536437 | hippocampus | .a | 1320 to 1652 | 67 to 403 | Submitted on the opposite strand | 337/404 (83 %) | 11 diff (97.3 %id) | ||
DB563904 | hypothalamus | .d-u | 1117 to 1572 | 1 to 456 | Submitted on the opposite strand | 456/456 (100 %) | 3 diff (99.4 %id) | ||
BP255241 | Kidney | .a | 89 to 670 | 1 to 582 | 582/582 (100 %) | 1 diff (99.9 %id) | |||
AV726317 | hypothalamus | .d-u | 99 to 818 | 1 to 710 | V13G F14S F15L V16G Y17I ... | 710/712 (99 %) | 40 diff (94.4 %id) | ||
N64599 | multiple sclerosis lesions | .d-u | 1194 to 1572 | 380 to 1 | 380/386 (98 %) | 3 diff (99.3 %id) | |||
N79924 | multiple sclerosis lesions | .d-u | 627 to 968 | 1 to 353 | 353/354 (99 %) | 27 diff (92.4 %id) | |||
AA563905 | colon, tumor | .a | 1160 to 1623 | 463 to 1 | 463/467 (99 %) | 6 diff (98.8 %id) | |||
AA609955 | .j | 33 to 458 | 431 to 6 | 426/431 (98 %) | 0 diff (100 %id) | ||||
AA769900 | pooled | .l-u | 33 to 414 | 382 to 1 | 382/382 (100 %) | 1 diff (99.8 %id) | |||
AA830467 | germinal center B cell | .a | 1522 to 1739 | 226 to 10 | 217/226 (96 %) | 0 diff (100 %id) | |||
AI023828 | .k | 1 to 452 | 455 to 5 | exact | tiling clone, | 451/455 (99 %) | 2 diff (99.6 %id) | ||
AI038426 | parathyroid gland, parathyroid tumor | .d-u | 1168 to 1577 | 421 to 12 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 410/421 (97 %) | 0 diff (100 %id) | |
AI167568 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .d-u | 1357 to 1777 | 1 to 420 | Submitted on the opposite strand | 420/420 (100 %) | 2 diff (99.6 %id) | ||
AI167667 | parathyroid gland, parathyroid tumor | .d-u | 1131 to 1577 | 452 to 6 | 447/452 (98 %) | 0 diff (100 %id) | |||
AI476637 | pooled | .e | 1 to 397 | 399 to 3 | G16D Q17R G18A A19Q A20H ... | tiling clone, | 397/399 (99 %) | 2 diff (99.5 %id) | |
AI636448 | Kidney, renal cell tumor | .d-u | 1168 to 1573 | 406 to 1 | 406/406 (100 %) | 0 diff (100 %id) | |||
AI628601 | Kidney | .d-u | 932 to 1395 | 467 to 4 | tiling clone, | 464/467 (99 %) | 0 diff (100 %id) | ||
AI650773 | Kidney | .a | 1194 to 1740 | 543 to 1 | tiling clone, | 543/549 (98 %) | 19 diff (96.6 %id) | ||
AI701144 | carcinoid, lung | .d-u | 474 to 1005 | 1 to 531 | K49X | Submitted on the opposite strand | 531/531 (100 %) | 1 diff (99.9 %id) | |
AI764981 | Kidney | .a | 1058 to 1651 | 594 to 1 | 594/595 (99 %) | 3 diff (99.5 %id) | |||
AI765535 | 2 pooled tumors (clear cell type), Kidney | .d-u | 965 to 1573 | 612 to 3 | 610/612 (99 %) | 0 diff (100 %id) | |||
AW135240 | .c | 19 to 415 | 414 to 18 | tiling clone, AAA | Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) | 397/397 (100 %) | 4 diff (99.0 %id) | ||
AW136869 | .c | 1 to 415 | 432 to 18 | A54S | tiling clone, AAA | Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) | 415/415 (100 %) | 2 diff (99.6 %id) | |
BF511973 | .a | 1527 to 1740 | 231 to 18 | AAA | Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) | 214/214 (100 %) | 6 diff (97.2 %id) | ||
BF001346 | Prostate | .d-u | 1360 to 1923 | 1 to 564 | tiling clone, | Submitted on the opposite strand | 564/564 (100 %) | 1 diff (99.9 %id) | |
BF432356 | brain, glioblastoma (pooled) | .d-u | 1042 to 1575 | 534 to 1 | 534/534 (100 %) | 2 diff (99.7 %id) | |||
BE544307 | cervical carcinoma cell line, cervix | .a | 153 to 882 | 1 to 724 | 724/736 (98 %) | 12 diff (98.4 %id) | |||
BF792853 | adrenal cortex carcinoma, cell line, adrenal gland | .a | 561 to 1393 | 1 to 826 | AAA | 826/992 (83 %) | 29 diff (97.1 %id) | ||
BG114836 | duodenal adenocarcinoma, cell line, small intestine | .a | 139 to 910 | 1 to 762 | 762/951 (80 %) | 30 diff (96.9 %id) | |||
BI830704 | brain, medulla | .g-u | 2 to 724 | 1 to 731 | I21V L42H L43T E44* | tiling clone, | 731/908 (80 %) | 16 diff (98.3 %id) | |
BI596422 | brain, hypothalamus | .a | 98 to 860 | 1 to 764 | 764/765 (99 %) | 8 diff (99.0 %id) | |||
BI669317 | brain, hypothalamus | .a | 98 to 759 | 1 to 680 | 680/680 (100 %) | 28 diff (95.9 %id) | |||
BM142316 | Islets of Langerhans, Pancreas | .d-u | 1189 to 1577 | 1 to 389 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 389/397 (97 %) | 1 diff (99.8 %id) | |
BC064629 | Duodenum, adenocarcinoma | .b | 1 to 1801 | 1 to 1801 | exact | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) | 1801/1801 (100 %) | 2 diff (99.9 %id) |
BM558593 | duodenal adenocarcinoma, cell line, small intestine | .b | 2 to 885 | 1 to 900 | R175P M176N S177V S178L A179C | available from MGC, | 900/1040 (86 %) | 25 diff (97.6 %id) | |
BM920643 | pooled brain, lung, testis | .a | 143 to 1063 | 1 to 932 | 932/1044 (89 %) | 16 diff (98.5 %id) | |||
BQ271751 | Pancreas, Purified pancreatic islet | .a | 1090 to 1650 | 563 to 1 | 563/563 (100 %) | 2 diff (99.7 %id) | |||
BQ272070 | Pancreas, Purified pancreatic islet | .a | 148 to 723 | 10 to 585 | 576/585 (98 %) | 6 diff (99.0 %id) | |||
CK825590 | Pancreas, Purified pancreatic islet | .a | 215 to 602 | 1 to 388 | Submitted on the opposite strand | 388/388 (100 %) | 7 diff (98.2 %id) | ||
BQ014248 | Chondrosarcoma, Left Pubic Bone | .a | 1019 to 1651 | 651 to 19 | AAA | Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) | 633/633 (100 %) | 0 diff (100 %id) | |
CA772166 | Pancreas, Purified pancreatic islet | .d-u | 919 to 1571 | 653 to 1 | fully sequenced, | 653/653 (100 %) | 1 diff (99.9 %id) | ||
CA772465 | Pancreas, Purified pancreatic islet | .d-u | 711 to 949 | 1 to 239 | fully sequenced, | 239/239 (100 %) | 0 diff (100 %id) | ||
CA772182 | Pancreas, Purified pancreatic islet | .d-u | 470 to 1091 | 1 to 622 | exact | Submitted on the opposite strand | 622/622 (100 %) | 2 diff (99.7 %id) | |
CA866516 | Pancreas, Purified pancreatic islet | .a | 229 to 725 | 1 to 497 | 497/497 (100 %) | 0 diff (100 %id) | |||
CA866785 | Pancreas, Purified pancreatic islet | .a | 1096 to 1650 | 555 to 1 | 555/555 (100 %) | 6 diff (99.0 %id) | |||
CA453418 | mixed (pool of 40 RNAs) | .d-u | 455 to 1077 | 33 to 664 | exact | 632/809 (78 %) | 27 diff (96.7 %id) | ||
CF994017 | Human Placenta, placenta | .a | 377 to 1088 | 29 to 738 | 710/739 (96 %) | 13 diff (98.3 %id) | |||
TI_57172878 | .g-u | 1 to 724 | 97 to 828 | I21V L42H L43T E44* | tiling clone, | 732/1005 (72 %) | 16 diff (98.5 %id) | ||
TI_45209280 | .a | 94 to 860 | 80 to 847 | 768/848 (90 %) | 10 diff (98.9 %id) | ||||
TI_44346036 | .a | 94 to 759 | 80 to 763 | 684/763 (89 %) | 30 diff (96.1 %id) | ||||
CB158028 | Liver | .d-u | 1 to 204 | 1 to 204 | 204/204 (100 %) | 0 diff (100 %id) | |||
BP297489 | .a | 136 to 718 | 1 to 582 | 582/582 (100 %) | 7 diff (98.8 %id) | ||||
NM_007076.2 | .a | 89 to 1739 | 1 to 1651 | exact | RefSeq, | 1651/1651 (100 %) | 0 diff (100 %id) | ||
DA687479 | .a | 36 to 398 | 2 to 364 | capped | 363/363 (100 %) | 1 diff (99.8 %id) | |||
DA807657 | brain | .a | 96 to 626 | 2 to 533 | capped | 532/532 (100 %) | 1 diff (99.9 %id) | ||
TI_1948079076 | .a | 262 to 1132 | 130 to 999 | 870/1136 (76 %) | 37 diff (96.8 %id) | ||||
TI_1948079077 | .a | 262 to 1205 | 124 to 1061 | 938/1333 (70 %) | 32 diff (97.6 %id) | ||||
TI_1948079078 | .a | 583 to 1613 | 1151 to 124 | 1028/1349 (76 %) | 0 diff (100 %id) | ||||
TI_1948079079 | .a | 719 to 1613 | 1007 to 118 | 890/1143 (77 %) | 0 diff (100 %id) | ||||
TI_1948079416 | .a | 262 to 1081 | 129 to 947 | 819/1123 (72 %) | 29 diff (97.5 %id) | ||||
TI_1948079417 | .a | 262 to 1260 | 123 to 1118 | 996/1400 (71 %) | 37 diff (97.4 %id) | ||||
TI_1948079418 | .a | 551 to 1613 | 1174 to 125 | 1050/1346 (78 %) | 0 diff (100 %id) | ||||
TI_1948079419 | .a | 741 to 1613 | 986 to 124 | 863/1139 (75 %) | 0 diff (100 %id) | ||||
TI_1948079765 | .a | 262 to 868 | 129 to 739 | 611/1146 (53 %) | 18 diff (98.5 %id) | ||||
TI_1948079766 | .a | 262 to 1074 | 123 to 932 | 810/1382 (58 %) | 31 diff (97.8 %id) | ||||
TI_1948079767 | .a | 528 to 1613 | 1206 to 124 | 1083/1371 (78 %) | 0 diff (100 %id) | ||||
TI_1948079768 | .a | 663 to 1613 | 1054 to 120 | 935/1157 (80 %) | 0 diff (100 %id) | ||||
TI_1948080121 | .a | 262 to 982 | 129 to 854 | 726/1213 (59 %) | 30 diff (97.6 %id) | ||||
TI_1948080122 | .a | 262 to 1130 | 124 to 989 | 866/1392 (62 %) | 29 diff (98.0 %id) | ||||
TI_1948080123 | .a | 629 to 1613 | 1107 to 124 | 984/1349 (72 %) | 0 diff (100 %id) | ||||
TI_1948080124 | .a | 790 to 1613 | 936 to 120 | 817/1134 (72 %) | 0 diff (100 %id) | ||||
BP356093 | .a | 136 to 716 | 1 to 581 | 581/581 (100 %) | 1 diff (99.9 %id) | ||||
DB010167 | colon, tumor tissue | .a | 99 to 569 | 2 to 472 | capped | 471/471 (100 %) | 0 diff (100 %id) | ||
DB027238 | testis | .h | 1 to 602 | 2 to 604 | V12G T13D E14* | tiling clone, capped | 603/603 (100 %) | 1 diff (99.9 %id) | |
DB042118 | testis | .a | 1 to 581 | 2 to 582 | tiling clone, capped | 581/581 (100 %) | 0 diff (100 %id) | ||
DB062648 | testis | .d-u | 1215 to 1766 | 2 to 553 | to resequence, capped | 552/552 (100 %) | 0 diff (100 %id) | ||
DB339408 | testis | .d-u | 2617 to 3169 | 554 to 1 | tiling clone, to resequence, | 554/554 (100 %) | 3 diff (99.5 %id) | ||
TI_159701744 | .d-u | 700 to 1575 | 1005 to 136 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 870/1138 (76 %) | 0 diff (100 %id) | ||
TI_227714241 | .a | 782 to 1765 | 1036 to 61 | tiling clone, | 976/1066 (91 %) | 0 diff (100 %id) | |||
TI_227714975 | .a | 774 to 1765 | 1043 to 64 | 980/1097 (89 %) | 0 diff (100 %id) | ||||
BM968049 | lung, Primary Lung Epithelial Cells | .d-u | 456 to 1090 | 1 to 635 | exact | tiling clone, | Submitted on the opposite strand | 635/635 (100 %) | 1 diff (99.9 %id) |
CA314742 | Human Lung Epithelial cells, lung | .d-u | 875 to 1577 | 719 to 17 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 703/719 (97 %) | 0 diff (100 %id) | |
CB242173 | Human Lung Epithelial cells, lung | .a | 879 to 1651 | 791 to 19 | AAA | Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) | 773/773 (100 %) | 2 diff (99.8 %id) | |
BU627471 | Bone, Enchondroma cell line | .d-u | 900 to 1577 | 690 to 17 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 674/690 (97 %) | 0 diff (100 %id) | |
CA428951 | Cell Line, Chondrosarcoma | .a | 1492 to 1740 | 268 to 19 | AAA | Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) | 250/250 (100 %) | 1 diff (99.6 %id) | |
BU620317 | Cell Line, Chondrosarcoma | .a | 995 to 1740 | 759 to 19 | AAA | Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) | 741/744 (99 %) | 9 diff (98.8 %id) | |
CD365405 | Alveolar Macrophage, lung | .a | 1002 to 1739 | 756 to 19 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 738/738 (100 %) | 2 diff (99.8 %id) | |
CD364955 | Alveolar Macrophage, lung | .a | 995 to 1739 | 764 to 19 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 746/746 (100 %) | 2 diff (99.8 %id) | |
BI480878 | Native Retinal Pigment Epithelium sheets, retina | .a | 583 to 1613 | 1151 to 124 | Submitted on the opposite strand | 1028/1349 (76 %) | 0 diff (100 %id) | ||
CD678144 | eye, Trabecular meshwork | .a | 719 to 1613 | 1007 to 118 | Suspected internal deletion, this clone was ignored | 890/1143 (77 %) | 0 diff (100 %id) | ||
CD678145 | eye, Trabecular meshwork | .a | 262 to 1081 | 129 to 947 | Suspected internal deletion, this clone was ignored | 819/1123 (72 %) | 29 diff (97.5 %id) | ||
AV725594 | hypothalamus | .a | 262 to 1260 | 123 to 1118 | Suspected internal deletion, this clone was ignored | 996/1400 (71 %) | 37 diff (97.4 %id) | ||
AI014985 | .a | 551 to 1613 | 1174 to 125 | This clone was ignored | 1050/1346 (78 %) | 0 diff (100 %id) | |||
AI635509 | pooled germ cell tumors | .a | 741 to 1613 | 986 to 124 | This clone was ignored | 863/1139 (75 %) | 0 diff (100 %id) | ||
AI971699 | pooled germ cell tumors | .a | 262 to 868 | 129 to 739 | This clone was ignored | 611/1146 (53 %) | 18 diff (98.5 %id) | ||
BF592944 | pooled germ cell tumors | .a | 262 to 1074 | 123 to 932 | This clone was ignored | 810/1382 (58 %) | 31 diff (97.8 %id) | ||
TI_1948079767 | .a | 528 to 1613 | 1206 to 124 | 1083/1371 (78 %) | 0 diff (100 %id) | ||||
TI_1948079768 | .a | 663 to 1613 | 1054 to 120 | 935/1157 (80 %) | 0 diff (100 %id) | ||||
TI_1948080121 | .a | 262 to 982 | 129 to 854 | 726/1213 (59 %) | 30 diff (97.6 %id) | ||||
TI_1948080122 | .a | 262 to 1130 | 124 to 989 | 866/1392 (62 %) | 29 diff (98.0 %id) | ||||
TI_1948080123 | .a | 629 to 1613 | 1107 to 124 | 984/1349 (72 %) | 0 diff (100 %id) | ||||
TI_1948080124 | .a | 790 to 1613 | 936 to 120 | 817/1134 (72 %) | 0 diff (100 %id) | ||||
BP356093 | .a | 136 to 716 | 1 to 581 | 581/581 (100 %) | 1 diff (99.9 %id) | ||||
DB010167 | colon, tumor tissue | .a | 99 to 569 | 2 to 472 | capped | 471/471 (100 %) | 0 diff (100 %id) | ||
DB027238 | testis | .h | 1 to 602 | 2 to 604 | V12G T13D E14* | tiling clone, capped | 603/603 (100 %) | 1 diff (99.9 %id) | |
DB042118 | testis | .a | 1 to 581 | 2 to 582 | tiling clone, capped | 581/581 (100 %) | 0 diff (100 %id) | ||
DB062648 | testis | .d-u | 1215 to 1766 | 2 to 553 | to resequence, capped | 552/552 (100 %) | 0 diff (100 %id) | ||
DB339408 | testis | .d-u | 2617 to 3169 | 554 to 1 | tiling clone, to resequence, | 554/554 (100 %) | 3 diff (99.5 %id) | ||
TI_159701744 | .d-u | 700 to 1575 | 1005 to 136 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 870/1138 (76 %) | 0 diff (100 %id) | ||
TI_227714241 | .a | 782 to 1765 | 1036 to 61 | tiling clone, | 976/1066 (91 %) | 0 diff (100 %id) | |||
TI_227714975 | .a | 774 to 1765 | 1043 to 64 | 980/1097 (89 %) | 0 diff (100 %id) | ||||
BM968049 | lung, Primary Lung Epithelial Cells | .d-u | 456 to 1090 | 1 to 635 | exact | tiling clone, | Submitted on the opposite strand | 635/635 (100 %) | 1 diff (99.9 %id) |
BM968049 | lung, Primary Lung Epithelial Cells | .d-u | 456 to 1090 | 1 to 635 | exact | tiling clone, | Submitted on the opposite strand | 635/635 (100 %) | 1 diff (99.9 %id) |
CA314742 | Human Lung Epithelial cells, lung | .d-u | 875 to 1577 | 719 to 17 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 703/719 (97 %) | 0 diff (100 %id) | |
CA314742 | Human Lung Epithelial cells, lung | .d-u | 875 to 1577 | 719 to 17 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 703/719 (97 %) | 0 diff (100 %id) | |
CB242173 | Human Lung Epithelial cells, lung | .a | 879 to 1651 | 791 to 19 | AAA | Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) | 773/773 (100 %) | 2 diff (99.8 %id) | |
CB242173 | Human Lung Epithelial cells, lung | .a | 879 to 1651 | 791 to 19 | AAA | Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) | 773/773 (100 %) | 2 diff (99.8 %id) | |
BU627471 | Bone, Enchondroma cell line | .d-u | 900 to 1577 | 690 to 17 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 674/690 (97 %) | 0 diff (100 %id) | |
BU627471 | Bone, Enchondroma cell line | .d-u | 900 to 1577 | 690 to 17 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 674/690 (97 %) | 0 diff (100 %id) | |
CA428951 | Cell Line, Chondrosarcoma | .a | 1492 to 1740 | 268 to 19 | AAA | Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) | 250/250 (100 %) | 1 diff (99.6 %id) | |
CA428951 | Cell Line, Chondrosarcoma | .a | 1492 to 1740 | 268 to 19 | AAA | Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) | 250/250 (100 %) | 1 diff (99.6 %id) | |
BU620317 | Cell Line, Chondrosarcoma | .a | 995 to 1740 | 759 to 19 | AAA | Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) | 741/744 (99 %) | 9 diff (98.8 %id) | |
BU620317 | Cell Line, Chondrosarcoma | .a | 995 to 1740 | 759 to 19 | AAA | Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) | 741/744 (99 %) | 9 diff (98.8 %id) | |
CD365405 | Alveolar Macrophage, lung | .a | 1002 to 1739 | 756 to 19 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 738/738 (100 %) | 2 diff (99.8 %id) | |
CD365405 | Alveolar Macrophage, lung | .a | 1002 to 1739 | 756 to 19 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 738/738 (100 %) | 2 diff (99.8 %id) | |
CD364955 | Alveolar Macrophage, lung | .a | 995 to 1739 | 764 to 19 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 746/746 (100 %) | 2 diff (99.8 %id) | |
CD364955 | Alveolar Macrophage, lung | .a | 995 to 1739 | 764 to 19 | AAA | Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) | 746/746 (100 %) | 2 diff (99.8 %id) |